Randomized trial of valopicitabine (NM283), alone or with peginterferon, vs. retreatment with peginterferon plus ribavirin (PEGIFN/RBV) in hepatitis C patients with previous non-response to PEGIFN/RBV : first interim results

収録刊行物

• Hepatology

  Hepatology 42 (1), 234A-, 2005